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Abstract: This study examines how diversity in R&D collaboration partners 
affects the innovation performance, as measured by each firm’s sales share of 
innovative products taking into account the research versus development 
orientation of firms. To address this question, a large-scale sample of firm-level 
data from six waves (1999, 2002, 2005, 2008, 2011 and 2013) of the Swiss 
innovation survey is examined using a heteroscedastic-robust Tobit regression 
method. Results suggest that diversity positively affects the innovation 
performance of both firm types, but that the effects are strongest for research-
oriented firms. In line with theoretical reasoning, a clear inverted U-shaped 
relationship between partner diversity and innovation performance is detected 
only for development-oriented firms and differences in effects are most 
pronounced for new-to-the-market innovations. In light of our findings, the 
study stresses the importance of partner diversity for research-oriented firms 
and (vertical) partner selectivity for development-oriented firms. 
Keywords: R&D collaboration; R&D diversity; R&D partners; research 
orientation; development orientation; cooperation strategies; innovation 
performance; market novelties. 
 
1  Introduction 
The growing interest in openness in innovation – including industry-science collaboration 
– deserves more attention regarding the role of inter- and intra-organizational structures 
of knowledge creation and exchange. In-depth knowledge concerning both the 
opportunities and pitfalls of openness in organizations is highly needed. Indeed, the 
current literature calls for more research to better understand optimal organizational 
structures that explains how to effectively integrate knowledge from external sources into 
organizations (Cassiman and Veugelers, 2006; Dahlander and Gann, 2010; Laursen and 
Salter, 2014; Leiponen and Helfat, 2010; Sampson, 2007; Wallin and Von Krogh, 2010). 
This study examines how diversity in R&D collaboration affects innovation performance 
of research- versus development-oriented firms. Specifically, we derive more 
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understanding for answers to questions such as, ‘what are optimal levels of diversity of 
collaboration partners accounting for the research versus development orientation of 
firms?’  
Empirical research indicates that a firm’s innovation performance benefits from a 
higher collaboration intensity (Hottenrott and Lopes-Bento, 2014a) and from more 
diversity in its collaboration network (Beck and Schenker–Wicki, 2014), but also 
suggests that the marginal returns of collaboration are decreasing (“curvilinear effect”). 
These findings underline the importance of striking an appropriate balance between 
excessively broad and narrow search in the context of collaboration (Laursen and Salter, 
2006). While recent studies have repeatedly confirmed the inverted U-shaped relationship 
between the diversity of collaboration partnerships and innovation performance, there is a 
gap of understanding of how this balance is affected when important firm characteristics 
and activities are taken into account. This study intends to fill this gap, and particularly 
considers an important dimension, which has so far not been addressed in this context: 
the firms’ orientation towards research versus development activities. 
While ‘R’ and ‘D’ have been mainly treated together in empirical work (Czarnitzki et 
al., 2011), it has long been pointed out that they relate to different environments 
(Mansfield, 1981) and firm structures (Link, 1982) and also constitute distinct activities 
per se (Barge-Gil and López, 2014). In this context, the risks and uncertainties commonly 
associated with R&D tend to be more pronounced in ‘R’ than in ‘D’ (Czarnitzki et al., 
2011). Although these claims appear to have gone largely uncontested, the number of 
studies systematically distinguishing between ‘R’ and ‘D’ has remained low. Recently, 
however, there has been a slight resurgence of interest in this research-development 
dichotomy (Barge-Gil and López, 2015). A number of studies has recently analyzed the 
roles of public support and financial constraints as determinants of ‘R’ and ‘D’ activity 
(Clausen, 2009; Hottenrott et al., 2014); as well as the differentiated effects of ‘R’ and 
‘D’ on innovation (Czarnitzki et al., 2009; Czarnitzki and Thorwarth, 2012; Karlsson et 
al., 2004). Surprisingly, however, such a distinction between ‘R’ and ‘D’ has not been 
systematically applied to the important context of collaboration diversity. This project 
aims to make a first step in this direction, by examining how R&D collaboration with 
diverse partners impacts innovation performance of research- OR development-oriented 
firms.  
Specifically, following theoretical reasoning, this study investigates if the effect of 
partner diversity is stronger for research than for development-oriented firms. 
Additionally, as we assume that the relative marginal benefits of additional partners are 
smaller for development-oriented firms, we anticipate the inverted U-shape relationship 
between partner diversity and innovation performance is more pronounced for 
development-oriented firms. Moreover, in line with the economic rationale that diversity 
provides firms with more technological opportunities, the effects of diversified 
collaboration should be more pronounced for radical innovation outcomes. Finally, we 
are interested in how the geographical diversity of partners as well as partner type 
composition affect innovation outcomes of research- versus development-oriented firms. 
As an additional robustness test, we estimate if the effects are affected by the degree of 
innovation novelty.  
To address our research questions, the study uses a methodology similar to previous 
studies in this field (Beck and Schenker–Wicki, 2014; de Leeuw et al., 2014; Faems et 
al., 2005). Like these studies, the analysis is based on innovation survey data, employs a 
Tobit regression method to estimate the effects of partner diversity on innovation 
 performance and uses a set of widely accepted controls, and robustness checks. The 
group-specific effects of partner diversity are identified and compared by means of 
separate subsamples of research- and development-oriented firms, which closely follow 
typical features of research and development taken from theory.  
In a nutshell, our results point to the importance of partner diversity for research-
oriented firms and (vertical) partner selectivity for development-oriented firms. These 
results suggest that diversity positively affects innovation performance of both firm types, 
but that the effects are stronger for research-oriented firms. In line with theoretical 
predictions, a clear inverted U-shaped relationship between partner diversity and 
innovation performance is detected only for development-oriented firms and differences 
are more pronounced for more radical innovations which are new to the market. 
Interestingly, for research-oriented firms (given their frequent use of ‘Science only’ 
collaboration), there is ample evidence that for these firms, relying on a single science 
partner is usually not enough. Development-oriented firms, on the other hand, seem to 
benefit from selectivity in terms of their most used partner, namely by collaboration with 
vertical partners, notably, even when they are used in isolation.  
Our research project contributes to the understanding of how firms in R&D alliances 
can enhance their innovativeness through a careful selection of their collaboration 
partners. This project clearly highlights the importance of alliance portfolio diversity for 
research-oriented firms and of portfolio selectivity for development-oriented firms. 
Strongly development-oriented firms need to be especially aware of the downsides of an 
excessively broad collaboration strategy, whereas strongly research-oriented firms may 
want to make more extensive use of such diversity.  
2 Theoretical background 
Joints effects of partnership 
In the context of this paper, the resource-based perspective is particularly important to 
explain the distinct benefits which diverse collaboration can offer for research- and 
development-oriented firms in overcoming specific innovation obstacles. Furthermore, to 
give appropriate weight to the cost dimension of diverse collaboration, this perspective is 
complemented with transaction cost reasoning (Das and Teng, 2000; Penrose, 1959).1 
According to resource-based view, a firm needs to develop and strengthen its own 
resource base in order to achieve and maintain a sustainable competitive advantage.  
To that end, collaboration can allow a firm to aggregate, share or exchange valuable 
resources with other organizations, especially resources, which it cannot efficiently create 
on its own or obtain through exchanges, mergers or acquisitions (Das and Teng, 2000). In 
particular, this can help firms pooling resources and exploiting resource 
complementarities, for example by jointly developing new products, the costs of which 
are beyond the capacity of an individual company. Hence, firms look to compensate for 
                                                
1 As Tsang (2000) notes, the transaction cost and resource-based explanations are in part 
complementary. Resource-based theory and transaction cost economics are two essential 
‘lenses’ used for the examination of joint ventures, and they are also specifically applied 
to studies of R&D cooperation (e.g. De Leeuw et al., 2014; Hottenrott & Lopes-Bento, 
2014). 
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what they lack internally by searching for partners with resource configurations which 
best complement their own (Das and Teng, 2000). Particularly for successful innovation, 
the variety of resources required by a firm tends to be quite large (Teece, 1986). This can 
give cooperation a natural place in firms’ development and exploitation of resources 
(Bogers and West, 2012). 
As the outlined perspectives already suggest, firms’ innovativeness can be enhanced, 
and sometimes even dependent upon, cooperation with external partners (Freeman, 
1991). These may include universities and other research organizations (Jaffe, 1989), 
suppliers and users (Shaw, 1994), and even other firms (Coombs, 1996). Between these 
partners, there exists a vast heterogeneity in motives and purposes: in fact, each partner 
type can perform different functions and present distinct challenges (Sakakibara, 1997). 
Given this heterogeneity, it seems important to disaggregate R&D cooperation by partner 
type. The literature distinguishes between three broad categories of partners: (a) 
Partnerships with science, consisting of universities and other research institutions; (b) 
Vertical partnerships, consisting of customers and suppliers as well as (c) Horizontal 
partnerships, consisting of firms of the same industry. According to Belderbos, Carree, 
Diederen, et al. (2004) and Bolli and Woerter (2013) distinct motives and challenges are 
commonly associated with each partner. 
This previous understanding of R&D collaboration has treated different partnerships 
as separate entities, largely independent from each other. However, given the increased 
speed and complexity of the technological environment, a single partner is rarely going to 
offer all solutions (de Leeuw et al., 2014). A considerable part of today’s firms, therefore, 
maintains multiple partnerships at the same time (Belderbos et al., 2006). These 
aggregated effects between these partnerships can be more then the mere sum of their 
partial effects: as the previously outlined heterogeneity of functions suggests, different 
partner types may serve different purposes, potentially on different stages of the 
innovation process (Czarnitzki and Hottenrott, 2012). Following this rationale, it is easily 
conceivable that the effects of working with partners can be interdependent. For instance, 
searching for new research findings together with universities may only translate into 
successful product innovation if the focal firm is also able to effectively select, combine 
and transform these ideas into relevant products for the consumer.1 For the latter purpose, 
collaboration with customers may be more effective and thus increase the standalone 
value of collaboration with universities. Conversely, working with universities may 
increase the standalone value of cooperating vertically, by providing fresh ideas and 
preventing the focal firm from being stuck in an existing trajectory. This would give rise 
to complementarities in the sense of (Milgrom and Roberts, 1995): cooperating with 
customers increases the marginal returns of cooperating with universities and vice-versa. 
Hence, rather than looking at the effects of a single partner, it becomes vital to also assess 
their effects jointly.  
Empirical evidence supports the idea that important complementarities effects exist 
between different partners. In particular, Belderbos et al. (2006) find evidence that 
cooperation with customers increases firms’ productivity growth both in combination 
with competitors and in combination with competitors and universities. Indeed, 
complementarities appear to exist between customer and competitor cooperation as well 
                                                
1 In the words of Doz et al. (2001), an organization which focuses only on ‘sensing’ is 
"knowledgeable but impotent" (p. 8): It has a plethora of good ideas but no effective 
structures to put them into practice. 
 as between customer and university cooperation. This is in line with the aforementioned 
idea that firms benefit from combining more basic forms of cooperation with forms of 
cooperation closer to the market: particularly customers may be instrumental in 
facilitating the acceptance and quick diffusion of innovations (Belderbos, Carree, 
Diederen, et al., 2004; Tether, 2002).1 
However, combinations between partner categories also do not show the whole 
picture. The fact that some firms have resorted to network strategies involving complex 
interactions of multiple partnerships (de Leeuw et al., 2014) calls for an additional unit of 
analysis, the so-called ‘alliance portfolio’ (Faems et al., 2005; Wassmer, 2008). 
Alliance portfolio diversity 
Research concerned with such alliance portfolios, central to this paper, analyzes the focal 
firm and its alliances as an egocentric network. In this context, the alliance portfolio is 
defined as "the set of focal firm's active formal alliances" (de Leeuw et al., 2014, p. 
1840). Hence, ‘alliance portfolio diversity’ (APD) is defined as the number of 
idiosyncratic alliance forms. In assessing this idiosyncrasy, it has become common to 
account not only for the aforementioned partner categories, but to also consider other 
relevant dimensions, whose characteristics differ in non-trivial ways (de Leeuw et al., 
2014). This study follows Duysters and Lokshin (2011) and de Leeuw et al. (2014) in 
accounting for both partner types and their geographical distribution, distinguishing 
between domestic and cross-border partnerships.  
There are good reasons to draw on geography as an additional dimension: 
requirements for R&D cooperation with a partner abroad may include dealing with a 
different culture and language (Joshi and Lahiri, 2014), but also adjustments to new 
regulations and laws. Many of the related issues may have to be dealt with on a 
continuous basis and can apply even if the firm already cooperates with the same partner 
type domestically. At the same time, these cross-border partnerships can bring radically 
new knowledge and other resources compared to what domestic partners offer (Meyer-
Krahmer and Reger, 1999). Particularly firms requiring resources to innovate in new 
technological areas thus tend to cooperate intercontinentally (Miotti and Sachwald, 
2003). Hence, in the sense of Cook and Brown (1999), each ‘partner type / geography 
combination’ is here treated as a separate search and learning space, embedded in its own 
distinct environment with non-local individuals, involving potentially different routines, 
habits and norms. 
In general, drawing from such a diverse set of cooperation partners can be expected to 
affect firms’ innovativeness (Beck and Schenker–Wicki, 2014). Specifically, 
evolutionary economics (Nelson and Winter, 1982) points to the importance of a wide 
range of external sources in increasing the variety of knowledge in a firm. Such variety 
fosters the firm’s ability to create new combinations of technology and other knowledge 
(Laursen, 2012), and can thus increase its ability to innovate (Laursen and Salter, 2006). 
In that sense, diverse collaboration generally allows firms to access various 
                                                
1 By contrast, combining suppliers with universities or competitors seems to exhibit a 
sub-additive effect on labour productivity (Belderbos et al., 2006). According to the 
authors, this could be due to supplier cooperation being less compatible with the more 
radical nature of these cooperation agreements, or with spillovers of valuable scientific 
knowledge to suppliers or competitors. 
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complementary resources (including knowledge, cf. Hottenrott and Lopes-Bento (2014b), 
which help them overcome internal limitations and resulting uncertainties in their 
innovation processes.1 
However, as shown before, the logic of transaction cost economics also foreshadows 
some of the downsides of drawing from an excessive number of sources (cf. Laursen & 
Salter, 2006). More recently, research has started to place more emphasis on these 
limitations of broad innovation search processes (Laursen, 2012). The exploration of non-
linear effects has thus become a focal point of research in the field, also in the area of 
alliance portfolio diversity. 
The big picture: inverted U-shaped patterns 
Here, an interesting picture has emerged in repeated observations: APD appears to 
increase innovative output only up to a certain (‘tipping’) point, where the costs start to 
outweigh the benefits. In particular, Duysters and Lokshin (2011), Oerlemans et al. 
(2013), Beck and Schenker–Wicki (2014), de Leeuw et al. (2014) and Zouaghi et al. 
(2015) have reported such a curvilinear or ‘inverted U-shaped’ relationship between 
partner diversity and innovation performance. Such a pattern is also backed by other 
findings related to search breadth, such as Katila and Ahuja (2002) and Laursen and 
Salter (2006) on knowledge sources; von Raesfeld et al. (2012) on the technological 
diversity between project partners as well as Hottenrott and Lopes-Bento (2014b) on 
firms’ collaboration intensities.2 Overall, the prevailing evidence indicates significant 
negative effects of ‘over-searching’. 
The choice of additional cooperation partners is, therefore, a decision that requires a 
careful consideration of the associated costs (Beck & Schenker-Wicki, 2014). Given the 
partners’ embeddedness in distinct environments, each partner may require different 
organizational practices to manage (Laursen & Salter, 2006). With every new partner, the 
focal firm has to deal with new recurring issues such as coming to agreements, adapting 
the own organization, contracting and monitoring (Beers and Zand (2014), as well as the 
regulation of the appropriation of joint R&D results (Beck & Schenker-Wicki, 2014). 
Here, classic transaction cost drivers such as uncertainty and opportunism can come into 
play, giving rise to substantial costs related to the management, coordination and control 
of diverse partnerships (Knudsen and Mortensen, 2011). 
These transaction costs must be borne for all partners simultaneously and can quickly 
overburden the capacities of a firm. Certain risks, particularly the risk of opportunism and 
of involuntarily spillovers (Combs and Ketchen, 1999) are also expected to rise with the 
number of partners.3 Moreover, every investment in a partnership carries with it a degree 
                                                
1 The supposed positive effects of diverse cooperation have largely been supported 
empirically (e.g. Faems et al. (2005); Sampson (2007). Maintaining cooperative relations 
with diverse partners has been found to increase both the general likelihood of achieving 
product innovations (Becker & Dietz, 2004) as well as the specific likelihood of 
introducing more novel innovations (Nieto and Santamaria, 2007; Phelps, 2010).  
2 In the study by Hottenrott & Lopes-Bento (2014), collaboration intensity refers to the 
share of collaborative R&D projects in a firm’s total number of R&D projects.  
3 Laursen & Salter (2014) find evidence that the inverted U-shaped effects of 
appropriability on diverse formal partnerships (which are the object of this study) are 
 of dependency on the partner (Teece, 1986). If these dependencies become too manifold, 
such ‘over-embeddedness’ can jeopardize firm performance (Uzzi, 1997), especially in 
the case of unforeseen events (Lokshin et al., 2011).  
Given these rising costs and risks, managing diverse partnerships can constitute a 
highly unproductive drain of resources, unless each additional partner contributes 
substantial marginal benefits. These benefits may also be limited: every additional partner 
can only contribute so much useful information (Hottenrott and Lopes-Bento, 2014b), 
and firms with many partners may become subject to the ‘attention allocation problem’. 
Because decision-makers must focus their scarce attention on a limited number of issues 
(Koput, 1997), only a limited number of ideas (e.g. from diverse partnerships) can be 
given the level of serious attention required for implementation.1  
Hence, as Laursen and Salter (2006) and Phelps (2010) seem to suggest, 
innovativeness may be just as much dependent on an appropriate intensity of (repeatedly) 
engaging with a partner as it is on the number of diverse partner types.  
While the general limitations of diverse partnerships have thus become quite evident, 
it seems less clear whether they apply to most firms in a similar fashion.  
The role of research- and development-orientation 
An important limitation in much of the previous innovation literature is the treatment 
of R&D as an inseparable process (Czarnitzki et al., 2011; Karlsson et al., 2004). 
Although it may sometimes be convenient or even necessary to treat R&D as a 
homogenous entity, researchers have long argued that the relative importance of its 
subcomponents may be as important as their total amount (Barge-Gil and López, 2015; 
Mansfield, 1981). 
In essence, the umbrella term ‘R&D’ comprises three main components: basic 
research, applied research and development. Following the definitions given in the 
OECD Frascati Manual (2002), basic and applied research aim primarily at acquiring 
new knowledge, where only applied research has a particular application objective in 
view. By contrast, development draws from existing research results and/or practical 
experience, in order to create and implement new and improved products and processes. 
Hence, the most important and most salient differences are expected to be found between 
the two main components of research and development.  
In their pursuit of product innovations, R&D active firms place differing emphasis on 
these two components (as reflected by the heterogeneity in relative R- and D- 
expenditures). While some firms base their product innovations largely on development 
(i.e. using little or no internal research), other firms take a more basic approach and aim 
at creating novel products with a substantial internal research component.  
There is reason to suppose that these basic orientations matter for the way in which 
firms benefit from diverse collaboration. At the core of this idea are essential limitations, 
which limit inventive activity according to classic market failure theory and give rise to 
                                                                                                                     
stronger than the effects of appropriability on ‘softer’, more general forms of openness 
pertaining to the use of separate knowledge sources.  
1 Other sources of inefficient resource allocation may add to this, such as the pursuit of 
ambiguous goals between different partnerships. According to Belderbos et al. (2006), 
pursuing multiple partnerships may be particularly problematic when these involve 
multiple objectives.  
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uncertainty in firms’ innovation processes (Arrow, 1962; Nelson, 1959). Although these 
limiting factors can be ascribed to R&D as a whole (Martin and Scott, 2000), previous 
research has stressed that they are likely to be more applicable to ‘R’ than to ‘D’ 
(Czarnitzki and Hottenrott, 2012; Czarnitzki et al., 2011). Specifically, factors such as 
high project complexity and costs (Pisano, 1991), outcome uncertainty, intangibility, a 
lack of appropriability as well as related financing constraints are all expected to be more 
pronounced in the ‘R’ dimension of R&D. 
In sum, this suggests that the hurdles to be overcome for successful product 
innovation tend to be particularly high for product innovations with a substantial research 
component. This is also reflected by the particularly high and diverse innovation 
obstacles faced by research-oriented firms in the Swiss innovation survey, giving rise to 
particularly high uncertainties in their innovation processes. In such an environment, 
cooperation can be a particularly effective way of supporting innovative activities: as 
previously outlined from a resource-based perspective, collaboration can help firms 
overcome crucial innovation obstacles, by providing access to complementary resources 
which are beyond individual firms’ internal capacities (Park et al., 2002).1  
This is not the end of the story, however: where the crucial obstacles are particularly 
diverse – as tends to be the case in research – the benefits of combining different partners 
become important. In these contexts, a single partner is hardly sufficient to help a firm 
overcome all crucial obstacles (which is necessary for successful product innovation to 
result). However, different partner types can (each) make a valuable contribution to this 
end. 
A closer look at specific innovation obstacles may help illustrate this. Based on 
theory and data on innovation obstacles,2 a variety of research-specific obstacles can be 
identified which give rise to differing diversity benefits in the above sense. Among these 
are (a) a lack of information on the state of technology, (b) financing and regulatory 
constraints as well as (c) difficulties in transforming research knowledge into marketable 
products. Previous studies suggest that to overcome each of these three research-specific 
obstacles, different cooperation partners may be instrumental.  
(a) First, to mitigate the consequences of a lack of technological information, which 
should be particularly important in research (given its aim at acquiring new 
knowledge), science partners provide an affordable window to new technologies 
and allow firms to keep abreast of the latest developments (Tapon and Thong, 
1999). 
(b) Second, to mitigate financing constraints which have been found to be an 
important barrier to firms’ research activities (Czarnitzki et al., 2011), horizontal 
partners are found to be particularly valuable (Czarnitzki and Hottenrott, 2012),: 
for instance, by helping firms spread their high research costs in a consortium  
(Hagedoorn and Schakenraad, 1990), a larger number of projects can be pursued, 
thereby potentially increasing the probability of successes of R&D efforts 
(Kotabe and Scott Swan, 1995). Horizontal cooperation may also help research-
oriented firms to disseminate some of the project-specific risk (Tapon and Thong, 
                                                
1 Park et al. (2002), who study strategic alliances of semiconductor start-ups, find 
evidence that these firms (a) use strategic alliances to adapt to market uncertainties and 
(b) that ‘resource-poor’ firms are more likely to form such alliances. 
2 Results on the relative importance of innovation obstacles can be obtained from the 
authors. 
 1999) and signal the value of their intangible resources to investors (Czarnitzki 
and Hottenrott, 2012). As shown in the theory on the motives for horizontal 
cooperation, it can also be an effective way of dealing with regulatory problems 
(Nakamura, 2003). These tend to be especially high for research-oriented firms 
(see Figure 1), possibly due to the novel and sometimes-unknown nature of their 
products. 
(c) Third, research-oriented firms may find it particularly difficult to transform 
research knowledge into marketable and accepted products. For these purposes, 
vertical cooperation may be instrumental, as indicated by the previous theory. 
Hence, for successful innovation, research-oriented firms often tend to have a variety 
of specific obstacles to overcome. While each partner can make a valuable contribution to 
this end, often no single partner type is individually sufficient in helping a research-
oriented firm do so. Therefore, if research-oriented firms make use of cooperation for 
innovation, a combination of different partner types appears as the most beneficial 
strategy: by using them together and thus making use of their diversity, the odds of 
passing all research-specific hurdles can be significantly increased. 
For development-oriented firms, on the other hand, vertical cooperation seems 
instrumental. Given their closeness to the market and the relative continuity of their 
activities (Hottenrott et al., 2014; Karlsson et al., 2004), these firms are expected to profit 
extensively from continuous and sustained feedback loops along the value chain.1 A 
combination of vertical cooperation with other partner categories, however, is not 
expected to offer the same complementarities as it does for research-oriented firms. 
Based on theory, science and (even more so) horizontal partners appear to offer specific 
benefits to research-oriented firms that are largely absent for many development-oriented 
firms. Therefore, while potentially helpful to foster innovations, it does not seem vital (at 
least in the medium term) for these firms to complement vertical collaboration with these 
more basic cooperation forms. 
The supposed differences in diversity effects may be further compounded by effects 
of geographical diversity, especially in light of the fact that research-oriented firms seem 
to frequently target new geographical markets with their inventions.2 This is important, 
because some of the research-specific obstacles must be overcome both domestically and 
abroad. For instance, regulations for new products differ across countries, as does 
consumers’ acceptance of acceptance of new products. This points to additional benefits 
from geographically diverse partnerships for research-oriented firms. Previous studies 
indicate that particularly collaborating internationally can be an effective way for firms to 
facilitate expansion into these markets, to access local technological expertise and to 
reduce risks associated with new product introduction (Duysters and Lokshin, 2011). 
                                                
1 For instance, Leifer and Triscari (1987) suggest that especially development units 
should ideally maintain close links with actual or potential customers. 
2 While development-oriented firms rank the goal of ‘maintaining or increasing market 
share’ (in current markets) as a much more important goal of their product innovation 
activities, research-oriented firms indicate the goal of ‘accessing new regions as sales 
markets’ as significantly more important. Even after controlling for other important 
factors, these innovation goals, as well as the overall severity of innovation obstacles, 
remain significantly associated with research- and development-orientation). Seemingly 
unrelated bivariate probit regression results on R- or D-orientation are available upon 
request from the authors. 
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Overall, the marginal benefits of diverse cooperation are thus expected to be higher 
for research-oriented firms than for development-oriented firms. Meanwhile, the 
marginal costs are deemed to be similar among the groups, following the logic of 
transaction cost economics. In light of these theoretical predictions, the main hypothesis 
is clear: 
H1: The overall effect of partner diversity on innovation performance is stronger for 
research-oriented firms.  
The limited marginal benefits of additional partners for development-oriented firms 
further imply that for these firms, the costs of diverse partnerships have more of a 
bearing: because for development-oriented firms, the supposed marginal costs are large 
relative to the (moderate) marginal benefits, they are expected to catch up with the 
marginal benefits much sooner.1  
Hence, for these firms, the existence of a turning point can be expected over the 
observed range of partners, where the marginal benefits are more than offset by the 
marginal costs and beyond which the net benefits of cooperation decline rapidly. 
H2: For development-oriented firms, the relationship between partner diversity and 
innovation performance follows an inverted U-shape.  
Turning to the different subcomponents of innovation performance, more specific 
predictions can be made. As the previous part has established, particularly high (or 
diverse) obstacles must be overcome to bring about successful innovations with a strong 
internal research component. To better overcome these hurdles, cooperating with diverse 
partners can be an effective strategy. However, being faced with high hurdles may also 
end up having its advantages: once these high obstacles are overcome (i.e., the 
innovations are successfully realized and reach the marketplace), the inherent novelty 
potential of the resulting innovations tends to be greater. A firm that has pursued product 
innovation with basic research methods (and in the process, possibly ventured into 
previously unknown territories) may be rewarded with a finished product, which strongly 
differs from what has previously been known. 
Following this rationale, the effects of diverse cooperation in helping research-
oriented firms overcome their innovation obstacles should result particularly in 
innovations new to the market. In other words, the distinct effects on this outcome 
measure should be most pronounced.  
H3: The differences in effects are strongest on market novelties.  
While H1-H3 are assessed in terms of a ‘compound measure’ for alliance portfolio 
diversity (including both diversity in partner categories and geography), the previous 
arguments imply that even if these two types of diversity are disaggregated, diversity 
effects should still be observable. Therefore, an additional hypothesis concerns the 
separate effects of different partner combinations (vertical, horizontal and science) and 
geographical diversity (domestic and/or abroad). 
H4: Both in terms of partner categories and partner geography, diversity has a 
stronger impact on the innovation performance of research-oriented firms. 
                                                
1 An exemplary representation and simulation of the supposed relationships can be 
obtained from the authors. 
 Empirical strategy 
Data 
The empirical analysis uses micro-aggregated firm-level data of Swiss firms, derived 
from six waves of the Swiss innovation survey (years 1999, 2002, 2005, 2008, 2011 and 
2013). The Swiss innovation survey is a postal survey conducted by the KOF Swiss 
Economic Institute at ETH Zurich, based on a disproportionate stratified random sample 
of Swiss firms with at least five employees, covering all relevant manufacturing, service 
and construction sectors (Beck and Schenker–Wicki, 2014). In its setup, it is largely 
aligned to the European Community Innovation Survey (‘CIS’), which is based on OECD 
guidelines (OECD, 1992). The survey is therefore subject-oriented, periodically asking 
firms to provide detailed information on their R&D and innovation activities as well as 
on structural characteristics and market conditions.1 After eliminating non-innovating 
firms, missing observations and firms without indication of R&D expenditures, the main 
sample contains 1,903 firms and 3,757 observations.2 
Outcome Measures 
Because CIS data are widely used and many of the above-mentioned empirical studies 
are CIS-based, this data allow for the use of widely accepted measures. 
The main dependent variable is each firm’s innovation performance, as measured by 
the share of new or significantly improved product turnover in total firm turnover 
(INNO_SALES), ranging from 0 to 100. Following the Oslo Manual (OECD, 1992), 
products must be (at least) new to the firm or modified in a substantial way to conform to 
this definition.3 This measure for innovation performance has been used in several key 
contributions (Belderbos, Carree and Lokshin, 2004; Grimpe and Kaiser, 2010) (Duysters 
and Lokshin, 2011) and has gained widespread acceptance in empirical analysis. 
We follow influential studies in the field in employing a time lag for the outcome 
variable Belderbos et al. (2006) regarding the effects on productivity growth and 
similarly de Leeuw et al. (2014) for innovation performance). To allow for an appropriate 
time span during which the results of R&D collaboration can result in innovation 
performance, each firm’s innovation performance recorded in the subsequent survey 
wave is used, where available. Exactly corresponding to the assumption made by 
Belderbos, Carree and Lokshin (2004) for the effects of cooperation on productivity 
growth, it is therefore supposed that R&D collaboration in years (t-2) to (t) should have 
                                                
1 The response rates from the survey were 33.8% (1999), 39.6% (2002), 38.7% (2005), 
36.1% (2008), 35.9% (2011) and 32.7% (2013). 
2 As this study looks at research- and development-oriented firms and the effects of R&D 
collaboration, observations of firms indicating no importance of R&D expenditures could 
not be examined in addition to missing observations (1190 observations). Although the 
resulting omission of R&D inactive firms causes increases in firms’ average 
competitiveness (higher average values for variables such as R&D intensity and 
innovation performance), structural differences compared to the overall sample appear 
unsystematic. Still, the results should be interpreted for firms with R&D expenditures. 
3 This excludes products with only minor adjustments, such as mere design changes or 
customer specifications. 
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its main impact on product innovation in periods (t) to (t+2), where (t) denotes the year in 
which the survey was undertaken and (t+1) the following year.1 Although no 3-year 
period can capture the entire impact of R&D collaboration, such a time frame appears 
both proximate and long enough to capture the most important effects. At the same time, 
using a time lag may reduce simultaneity-related problems, which are quite common in 
innovation survey data (Mairesse and Mohnen, 2010). 
To provide further insights, additional regressions use subcomponents of innovative 
sales as their dependent variable, as depicted in Table 1 below.  
 
Table 1 Subcomponents of innovative sales 
(Overall) innovative sales: new or significantly improved products 
New products Sig. improved products 
Market novelties Firm novelties 
Main effects (alliance portfolio diversity and partner combinations) 
To examine how the diversity of partner types affects innovation performance 
(hypotheses 1-3), the alliance portfolio diversity (APD) is used as the main explanatory 
variable. As aforementioned, this variable is defined following Oerlemans et al. (2013) 
and de Leeuw et al. (2014), based on binary information on each firm’s partner types and 
their geographic distribution (domestic or abroad). Cooperative agreements are 
distinguished by means of seven partner types: customers, suppliers, competitors, non-
competing firms, firms belonging to the same corporate group, universities and other 
research institutions, each of whom constitutes a separate partner domestically and 
abroad. APD is then calculated by (a) dividing each firm’s number of partners by the 
maximum possible number of partners (in this case 14) and (b) taking the squared term of 
this division. To examine potentially important non-linear effects (Laursen and Salter, 
2006), a squared term of this APD variable (APD_Sq) is included (de Leeuw et al., 2014; 
Oerlemans et al., 2013). 
As a consistency check (hypothesis 4) and to gain further insights into the underlying 
complementarities, additional regressions examine the performance effects of (mutually 
exclusive) partner combinations. As shown in Beck and Lopes-Bento (2015), this 
amounts to eight constellations (Table 2):  
 
  
                                                
1 For instance, according to the exact wording of the Swiws innovation survey, the 2008 
survey (t) asks about collaboraiton activities from 2006 to 2008 (t-2 to t) and the 
subsequent 2011 survey asks about sales in 2010 resulting from products introduced 
since the beginning of 2008 (t to t+2).  
 Table 2 Operationalization of simultaneous partner combinations 
No. (S V H) Label 
1 (0 0 0) No partner category used 
2 (0 0 1) Horizontal only 
3 (0 1 0) Vertical only 
4 (1 0 0) Science only 
5 (0 1 1) Vert. & Hor. 
6 (1 0 1) Scie. & Hor. 
7 (1 1 0) Scie. & Vert. 
8 (1 1 1) All categories used 
Source: Modified from Beck and Lopes-Bento (2015). 
Controls 
Our analysis applies a set of well-established controls to limit unobserved firm and 
industry heterogeneity. Firstly, virtually all related studies control for firm size. Although 
its influence on the propensity to cooperate is ambiguous, it may influence the 
relationships in a variety of ways, especially in light of recently detected moderating 
effects ((Beck and Schenker–Wicki, 2014). Here, firm size is measured by the number of 
employees (regressed in terms of 100 employees, to facilitate interpretation). Because 
this variable is highly skewed, its values enter in logarithms (lnFIRMSIZE). Furthermore, 
non-linear effects of firm size on the propensity to collaborate (Cassiman and Veugelers, 
2002) are accounted for by using a squared term. 
Though closely related to firm size (Barge-Gil and López, 2014), firms’ age 
(FIRM_AGE) assumes a special role: young firms may be characterized by a particularly 
high degree of innovative activity (Czarnitzki and Hottenrott, 2012), especially to gain 
market access (Beck and Schenker–Wicki, 2014). 
A firm’s R&D activity is not only directly related to higher innovation performance, 
but it also tends to increase its ability to assimilate and exploit external information 
(Cohen and Levinthal, 1990). This renders it a potentially important factor for the degree 
to which firms can benefit from diverse partners. In line with other studies, each firm’s 
R&D intensity (RND_INT) is used to control for this ‘absorptive capacity’. However, 
internal R&D can only partly capture its effects (Sofka and Grimpe, 2010): authors have 
pointed to other important elements of a firm’s absorptive capacity, particularly human 
resources (Muscio, 2007; Rothwell and Dodgson, 1991). To capture these ‘softer’ 
determinants of absorptive capacity, we include a measure for the education level of the 
workforce, the share of employees with tertiary education (TERT_EDUC_SH) (Beck and 
Schenker–Wicki, 2014). Other important factors, which tend to influence the 
relationships of interest, can be found in a firm’s environment. For instance, firms 
competing in international markets tend to face more intense pressures to innovate 
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(Kirner et al., 2009). Following Abramovsky et al. (2009), de Faria et al. (2010), and 
Beck et al. (2016), regressions therefore include the share of firms’ exports in total 
turnover (EXPORT_SH), to proxy for the degree of competitiveness a firm is facing. 
The technological knowledge available in a firm’s environment, offering potential for 
innovations in its area of activity, may further influence both its propensity to cooperate 
and its innovative activity (TECH_POT). Finally, unobserved industry-specific and time-
varying effects are accounted for with 9 industry dummies and six year dummies for the 
respective survey waves. 
Estimation  
Taking into account that a significant share of the firms in the sample does not generate 
innovative sales in every given period, the outcome measures for innovation performance 
are characterized by a corner solution around zero (Tobin, 1958). To account for these 
censored dependent variables, Tobit models are used (left-censored at zero).1 Innovation 
performance is thus modelled as follows: 
INNO_SALES*i,t+1 = α + β1*APDi,t + β2*APD_Sqi,t + β3*lnFIRMSIZEi,t  
+ β4*lnFIRMSIZE_Sqi,t + β5*FIRMAGEi + β6*RND_INTi,t  + β7*TERT_EDUCi,t  
+ β8* EXPORT_SHi,t + β9*TECH_POTi,t + β10-18*SEC2-9i + β19-23*YEAR02t -
YEAR13t + ε, ε ~ i.i.d. N(0, σ2). 
whereas,  
INNO_SALESi, t+1  =   
	INNO_SALES		*,,-.∗ 	, if	 α	 + 	X*,,5 β + 	ε > 0			0, otherwise   (2) 
 
As stated by Wooldridge (2010), standard Tobit model estimation requires the 
assumption of homoscedasticity in order to be consistent. As likelihood ratio tests 
indicate the presence of severe heteroscedasticity in the regressions, heteroscedastic 
robust Tobit models are estimated by maximum likelihood, following Beck et al. (2016). 
In order to estimate heteroscedastic Tobit models consistently, the homoscedastic 
standard error term σ is to be replaced by σi = σexp(Z’α) in the likelihood function 
(Greene, 2003). Here, groupwise multiplicative heteroscedasticity is considered by 
including firm size and industry dummies.  
Furthermore, as many firms appear repeatedly in the sample, standard errors are 
clustered at the firm level. To test for significant between-group differences in APD 
coefficients, a Hausman-type test as described is used (de Leeuw et al., 2014). 
Besides, we perform additional regressions on the subcomponents of innovation 
performance in order to test the robustness of our results. Further robustness checks 
include a step-wise inclusion of additional controls; the exclusion of lagged dependent 
variables, and the omission of systematic outliers (R&D service firms) potentially 
causing between-group differences with potential influence on the results. 
                                                
1 Previous studies further point to Tobit regression models as the predominant method 
used to examine the effects of alliance portfolio diversity on innovation performance (e.g. 
Faems et al., 2005; Oerlemans et al., 2013; De Leeuw et al., 2014; Beck & Schenker-
Wicki, 2014). 
(1) 
 Categorization of firms 
As indicated previously, the essential between-group differences are assessed by means 
of subsamples of research- and development-oriented firms. To analyze firms’ ‘R’ and 
‘D’ as distinct activities, previous studies rely on firm-level expenditure data (e.g. Barge-
Gil & López, 2014; Hottenrott et al., 2014). Data on R&D expenditures is also collected 
in the Swiss innovation survey. Here, firms are asked to indicate the magnitude of their 
expenditures in research and development for their product innovation activities in 
Switzerland on a five-point Likert scale (from 1= ‘none’ to 5 = ‘very high’). It should be 
noted that this is a qualitative measure, unlike the quantitative measures used in other 
studies distinguishing between ‘R’ and ‘D’. However, it has been found that the 
informative content of the two measurement types tends to be similar (Arvanitis 
(Arvanitis and Hollenstein, 2001). Moreover, historical evidence (Godin, 2006)) and 
current accounting regulations suggest that firms may often lack systematic accounting 
practices to assess their separate research and development expenditures with precision. 
In that regard, the more qualitative data collected by the Swiss innovation survey may 
even be more reliable, as it is potentially less prone to measurement errors than survey 
data asking for absolute expenditures.  
Using this information, firms are categorized relying on the relative importance of R- 
and/or D- expenditures. For the creation of reliable subsamples, three essential 
preconditions had to be met: (a) The logic of the categorization should be in line with the 
basic idea outlined in the theoretical part, (b) the group characteristics should be 
consistent with theory and intuition and (c) the categorization should not be contaminated 
by systematic between-group differences which are unrelated to the relative importance 
of research and development and systematically influence other measures. 
The following categorization has been found to best fulfill all three criteria: A firm 
was categorized as research-oriented if its average indicated score of research 
expenditures for product innovation (during its participation in the survey) is at least as 
high as its average indicated score of development expenditures for product innovation, 
and as development-oriented otherwise.1 
(a) First, the result of this categorization closely adheres to the two basic 
approaches outlined in the theory part. On average, development-oriented firms 
indicate expenditure scores of (R/D)=(1.75/3.30), suggesting that their product 
innovations are largely based on development, whereas research-oriented firms 
indicate average scores of (3.01/2.90), suggesting that their product innovations 
contain a substantial internal research component.  
(b) Second, the categorization turned out to be highly consistent with theory and 
intuitive expectations. Both regarding key characteristics and collaboration 
patterns, research-oriented firms rank higher on dimensions, which are 
commonly associated to research, while development-oriented firms rank higher 
on typical development-related dimensions. 
(c) Third and perhaps most importantly, the categorization appears to be free from 
systematic between-group differences. In alternative categorizations based on 
                                                
1 More information on the detailed classification of firms into subsamples are available 
from the authors upon request.  
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relative R- and D-expenditures between firms, for instance, the firms with higher 
scores on the ‘R’ dimension would rank systematically higher on virtually every 
key indicator of innovativeness, including R&D cooperation. This is because 
firms with high scores on the research dimension usually also score high on the 
development dimension, but not necessarily vice-versa.1 Thus, a categorization 
of firms based on between-firm comparisons or absolute cut-offs would lead to 
highly unbalanced relationships. Here, high-profile innovators would 
systematically more often be assigned to the research-oriented group, giving rise 
to severe endogeneity problems. 
By directly comparing the R- and D- expenditures within firms, the categorization 
used in this study essentially gives each firm the same chance of being in either 
subsample, despite the existence of complementarities. In that way, this relative (within-
firm) categorization avoids systematic differences between the groups, while at the same 
time maintaining a high degree of consistency.2  
Results and discussion 
Descriptive statistics 
Table 3 shows summary statistics for the full sample of firms observed. Exactly as in 
De Leeuw et al. (2014) who examine the same 14 partners, the average APD for the full 
sample amounts to 0.04, corresponding to an average of 2.8 partner types. Overall, the 
magnitude of the variables is in line with expectations and the main variables are close to 
equal between the groups. However, regarding the controls, significant between-group 
differences in firm age, ‘tertiary education’ and R&D intensity seem noteworthy. While 
lower firm age, lower export shares and higher education levels in research-oriented 
firms are unsurprising based on previous research (e.g. Barge-Gil & López, 2014), the 
differences in R&D intensity merit closer attention.3  
For more detailed information of the group-specific characteristics, seemingly 
unrelated bivariate probit regressions were calculated to examine the association of 
                                                
1 This is highly consistent with the findings of previous studies, suggesting that the two 
activities exhibit complementarities (see e.g. Hottenrott & Lopes-Bento, 2014, for a 
detailed discussion). In other words, high ‘R’ rarely comes without high ‘D’ in a firm, but 
high ‘D’ often comes without high ‘R’. 
2 An important caveat of this categorization is that also firms with lower scores on both 
dimensions (e.g. 2/2) are categorized as either research- or development-oriented. 
However, this has not been found to cause any serious inconsistencies. In turn, it allows 
the following regressions to cover the entire spectrum of firms’ R&D intensities, with 
subsamples that allow for useful comparisons.  
3 These differences stem from outliers: all service firms with R&D intensity above 50% 
belong to commercial service branches, strongly suggesting that these are service firms 
with R&D as their core business. Due to the nature of their activities, these firms are 
systematically assigned to the group of research-oriented firms, significantly increasing 
the R&D intensity of this group. However, the associated between-group differences are 
not found to influence the key results. Because the outliers are genuine (no measurement 
errors), they are nevertheless included in the other regressions. Additional tables showing 
these results can be provided by the authors upon request. 
 various factors with the likelihood of an innovating firm being research- and 
development-oriented.1 Results are consistent with theory and expectations: most notably, 
the goal of ‘accessing new regions as sales markets’ and the ‘overall severity of 
innovation obstacles’ remain significantly associated with research-orientation, even 
when controlled against other important factors.  
Regarding these obstacles, the previous hypotheses relied on rather specific 
statements, which require consistency with the data. Figure 1 below thus presents 
information on 21 innovation obstacles, for a large share of the selected sample. Firstly, it 
can be seen that the two research-specific obstacles ‘lack of public support for technology 
diffusion’ and ‘lack of public support for research’ show the largest differences between 
research- and development-oriented firms (t=-6.04 and t = -6.06). This is reassuring in 
the sense that firms appear to have been categorized correctly. Beyond that, between-
group comparisons of obstacles indeed show significant differences in three key 
dimensions outlined previously: (a) technological information, (b) financing constraints 
(internal and external), and (c) regulation (including market access). These specific 
obstacles are expected to constitute major drivers of differing collaboration benefits.  
More detailed information of industry distributions shows further interesting 
patterns.2 Research-oriented firms are relatively frequent in chemicals industries (p = 
0.0000, which includes pharmaceuticals) as well as wholesale and retail trade (p = 0.0000 
and p = 0.0262, respectively). Development-oriented firms, on the other hand, appear to 
be most prevalent in ‘engineering-intensive’ industries, notably machinery & equipment 
(p=0.0000), electrical engineering (p = 0.0004) and electronics & instruments (p = 
0.0001). 
With regard to cooperation patterns, the expected tendencies can be discerned (see 
Table 5): vertical cooperation appears to be frequently used by development-oriented 
firms, while science cooperation tends to be more often utilized by research-oriented 
firms. Apart from that, there is a slight indication of differences in horizontal cooperation. 
However, these differences barely fail to reach conventional significance levels. 
 
 
 
                                                
1 Results are available by the authors. 
2 Results are available by the authors.  
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Table 3 Summary statistics and cross-correlation matrix 
No. Variable Obs. Mean S.D. Min. Max. y 1 2 3 4 5 6 7 8 
y Innovative sales 3,757 28.54 26.97 0 100 1.00         
1 APD 3,757 0.04 0.10 0 1 0.13 1.00        
2 Firm Size 3,757 258.56 1,237.12 1 39899 0.01 0.21 1.00       
3 Firm Size Squared 3,757 1,596,932 38,400,000 1 1.59E+09 0.00 0.12 0.90 1.00      
4 Firm Age 3,757 59.96 42.44 1 645 -0.14 0.03 0.06 -0.02 1.00     
5 R&D Intensity 3,757 2.92 7.27 0 178.79 0.25 0.13 0.01 0.00 -0.11 1.00    
6 Share Tert. Educated 3,757 7.37 12.65 0 100 0.13 0.12 0.04 0.00 -0.14 0.30 1.00   
7 Tech. Potential 3,757 50.92 27.42 0 100 0.19 0.19 0.07 0.03 -0.07 0.17 0.21 1.00  
8 Export share 3,757 37.29 37.66 0 100 0.21 0.23 0.03 -0.01 -0.05 0.22 0.13 0.24 1.00 
Notes: Firm size is here represented in original units.   
 
Table 4 Summary statistics by group and between-group differences 
Variables 
(Total N = 3757) 
R-oriented 
n = 637 
D-oriented 
n = 3,120 
Result of t-tests Tech. Potential on mean differences 
No. Variable name Mean S.D. Mean S.D. p-Value, incl. outliers p-Value, excl. outliers 
y Innovative sales 27.10 26.88 28.84 26.98 0.1384 0.0563* 
1 APD 0.04 0.12 0.04 0.10 0.2089 0.3187 
2 Firm Size 296.10 1373.11 250.90 1207.58 0.4008 0.4008 
3 Firm Size_Sq 1,970,135 4.1*107 1,520,736 2.3*107 0.7876 0.7792 
4 Firm Age 55.86 45.97 60.79 41.64 0.0075*** 0.0072*** 
5 R&D Intensity 3.72 10.59 2.76 6.38 0.0024*** 0.6564 
6 Share Tert. Educ. 8.60 15.27 7.12 12.03 0.0071*** 0.0876* 
7 Tech. Potential 50.71 29.10 50.96 27.06 0.8306 0.6419 
8 Export share 33.63 38.58 38.04 37.44 0.0070*** 0.0028*** 
Notes: The variable for technological potential has been rescaled to value range [0,100].
  
 
 
 
Figure 1 Relative impact of various obstacles on the innovation process 
-0.041 -0.021 -0.001 0.019 0.039 0.059
*** All obstacles  (n=3726)
* Internal funding (n=3732)
* External funding (n=3732)
Taxes (n=3732) ***
R&D personnel (n=3732)
Specialised personnel (n=3732)
* Information on state of technology (n=3730)
Marketing opportunities (n=3730)
Lack of acceptance of new technology (n=3727)
Organisational problems (n=3731)
*** Regulation in the domestic market (n=3731)
*** Labour market regulation for foreigners (n=3731)
** Environmental regulation (n=3731)
* Construction laws (n=3731)
High costs (n=3732)
Payback period too long (n=3732)
Ease of copying (n=3732) *
Technological risks (n=3732)
Market related risks (n=3732)
*** Restricted market access to the EU (n=3731)
*** Insufficient public support for research (n=3731)
*** Insufficient pub. supp. for tech. Diffusion (n=3731)
Deviation from industry average
Research-oriented firms
Development-oriented firms
Notes:
Obstacles were rescaled to value range [0,1] from 
a 5-point Likert scale and imputed by individual 
means for each individual, where data from the 
individual firm was available but missing in the 
current wave.
*** (**, *) denote significance levels for p-values 
of between-group differences: 1% (5%, 10%).
The obstacle 22 (lack of IT personnel) was 
excluded for lack of data.
Source: Swiss Economic Institute (KOF)
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Table 5 Collaboration partner types by subsample 
No. Label 
R-oriented firms 
(n=188 
cooperating) 
D-oriented firms 
(n=971 
cooperating) 
t-value of mean difference 
(D-R) 
1 Customers Y/N 58.5% 64.8% t =  1.6370 
p = 0.1019 
2 Suppliers Y/N 68.1% 68.8% t = 0.1919 
p = 0.8478 
3 Same industry (Comp.) Y/N 37.2% 32.9% t = -1.1641 
p = 0.2446 
4 Other industry (NComp.) Y/N 38.3% 38.7% t = 0.1095 
p = 0.9129 
5 Group Y/N 38.3% 41.6% t = 0.8436 
p = 0.3991 
6 Universities Y/N 62.2% 55.7% t = -1.6518* 
p = 0.0988 
7 Other Res. institutions (Y/N) 34.6% 27.3% t = -2.0272** 
p = 0.0428 
 Total 100% 100% - 
Note: 70.5% of research-oriented and 68.9% development-oriented firms 
cooperate with at least one partner (t =  -8.008, p = 0.4233). 
Impact of partner diversity on innovation performance 
Table 6 presents the results of the heteroscedastic-robust Tobit regressions with overall 
innovative sales as the dependent variable. In the table, blocks (1) and (2) constitute 
different model specifications and the sub columns show the results for the respective 
samples (full sample = sample of research-oriented firms + sample of development-
oriented firms). Overall, the results confirm the positive yet limited effects of partner 
diversity found in previous studies. Despite controls, the APD linear coefficient is 
significantly positive for the full sample (1). However, the simultaneously significant 
negative squared term indicates an inverted U-shaped pattern between APD and 
innovation performance, which exhibits a tipping point at about 10 partners (2).1 Beyond 
that, interesting differences can be discerned for research- and development-oriented 
firms. As indicated by the APD linear coefficients, partner diversity positively affects the 
innovation performance in both firm types, but to a lesser extent in development-oriented 
                                                
1 The estimated tipping point (or optimal APD) can be calculated by dividing the negative 
APD linear coefficient by 2 times the APD squared coefficient. This follows from a 
simple quadratic formula of the form f(x) = ax2 + bx + c, where b corresponds to the 
APD linear coefficient and a to the APD squared coefficient, which solves to to xTop = 
−b/2a when derived by x. Then, to calculate estimated optimal number of partner types, 
one simply reverses the calculation of the APD formula (by taking the square root of the 
optimal APD and multiplying it by 14, De Leeuw et al., 2014). 
  
firms (p=0.0299 for differences in the linear coefficient). Moreover, the existence of a 
clear inverted U-shape is detected only for development-oriented firms. Figure 2 presents 
the estimated patterns. 
 
 
Note: keeping control variables at their respective group means and modifying only APD. 
Figure 2 Estimated relationships: partner types and innovation performance 
 
Figure 3 Estimated relationships: partner types and market novelty sales 
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Table 6 APD and innovation performance: Tobit regression estimates 
Dependent variable: 
sales share of new and 
sig. improved products  
 (1) APD   (2) APD with squared term 
 Full Research Develop.  Full Research Develop. 
H1. APD  16.68*** 37.73*** 11.49**  31.84*** 36.43* 34.28*** 
  (4.504) (9.209) (5.094)  (9.416) (19.99) (10.44) 
H2. APD Squared      -28.98* 2.076 -45.29** 
       (15.80) (28.33) (18.09) 
Tipping point (opt. no. 
of Partners) 
     10.38 - 8.61 
         
Log Firm Size  -4.513*** -2.716 -5.449***  -4.689*** -2.707 -5.736*** 
  (1.582) (3.423) (1.805)  (1.584) (3.426) (1.807) 
Log Firm Size Sq.  1.166*** -0.000 1.737***  1.226*** 0.000 1.842*** 
  (0.448) (0.817) (0.533)  (0.449) (0.817) (0.535) 
Firm Age  -0.033*** -0.047* -0.035***  -0.034*** -0.047* -0.035*** 
  (0.011) (0.026) (0.013)  (0.011) (0.026) (0.013) 
R&D Intensity  0.620*** 0.575*** 0.672***  0.617*** 0.575*** 0.663*** 
  (0.072) (0.136) (0.087)  (0.072) (0.136) (0.087) 
Share Tert. Educ.  0.102** 0.216** 0.101*  0.101** 0.217** 0.101* 
  (0.049) (0.104) (0.055)  (0.049) (0.105) (0.055) 
Tech. Potential  0.102*** 0.002 0.119***  0.099*** 0.002 0.116*** 
  (0.018) (0.044) (0.020)  (0.018) (0.044) (0.020) 
Export Share  0.079*** 0.050 0.082***  0.078*** 0.050 0.081*** 
  (0.015) (0.036) (0.017)  (0.015) (0.036) (0.017) 
9 Industry Dummies  χ2 (8) = 157.36*** 
χ2 (8) = 
64.36*** 
χ2 (8) =  
124.69*** 
 χ2 (8) = 
158.00*** 
χ2 (8) = 
64.33*** 
χ2 (8) = 
126.15*** 
6 Year Dummies  χ2 (5) = 42.24*** 
χ2 (5) = 
6.30 
χ2 (5) = 
49.87*** 
 χ2 (5) = 
42.29*** 
χ2 (5) = 
6.25 
χ2 (5) = 
50.13*** 
Constant  14.88*** 22.12*** 13.67***  14.75*** 22.14*** 13.47*** 
  (2.051) (4.769) (2.275)  (2.051) (4.771) (2.274) 
Total observations   3,757 637 3,120  3,757 637 3,120 
(uncensored)  (3,116) (513) (2,603)  (3,116) (513) (2,603) 
Wald χ2   607.90*** 165.66*** 516.85***  611.39*** 165.61*** 523.61*** 
Prob > χ2  0.000 0.000 0.000  0.000 0.000 0.000 
Log Likelihood  -15,449 -2,539 -12,871  -15,447 -2,539 -12,868 
Notes:  Standard errors in parentheses (clustered at the firm level).  
*,(**,***) Denotes significance at the 10% (5%, 1%) test level. 
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Further analysis aims at examining the underlying relationships in more detail. 
Though not directly comparable, the results on subcomponents of innovative sales 
strongly indicate that the specific differences in effects are strongest with market 
novelties as the dependent variable.1 Although the estimated APD coefficients are larger 
for research-oriented firms with regard to all subcomponents of innovative sales, they are 
found to differ significantly only with market novelty sales as the dependent variable 
(p=0.0298). The estimated relationships between partner diversity and market novelty 
sales are presented in Figure 3. Here, the research-specific effects of partner diversity 
appear most pronounced. While a clear and strong inverted U-shape is indicated for 
development-oriented firms, a near-linear relationship is estimated for research-oriented 
firms.2 
As an extension to Beck & Schenker-Wicki (2014), the study furthermore examined 
whether the estimated effects of partner diversity differ significantly by firm size. This 
was done by interacting APD with the continuous firm size measure, to have both 
baseline effects and the interaction simultaneously in the model. Indeed, a negative 
interaction effect between firm size and APD was found for new product sales.3 
However, no conclusive differences regarding these interactions could be discerned 
between research-and development-oriented firms.  
Impact of partner combinations on innovation performance 
In order to explore the underlying mechanisms in more detail, further regressions 
disaggregate the APD measure, looking separately at (1) the effects of mutually exclusive 
partner combinations and (2) the use of partners domestically and/or abroad. 
Table 7 presents these results, again with innovation performance (overall innovative 
sales) as the dependent variable. Here, the positive effects of diversity on the innovation 
performance of research-oriented firms become even more clear: the coefficient for a 
combination of all partner categories (Vert. & Hor. & Scie.) has by far the highest 
                                                
1 Although the number of observations for firm and market novelties is smaller (fewer 
firms indicated these), no clear differences to the overall sample were detected, except for 
the loss of a survey wave, which has been accounted for in the regressions. Moreover, all 
observations examined in the regressions for subcomponents are also contained in the 
main regression for innovation performance, ensuring a degree of comparability. Tables 
for specific descriptive statistics can be provided by the authors. 
2 Detailed regression results with market novelties as the dependent variable can be 
provided by the authors upon request. The main results appear robust against other 
potentially relevant controls, are largely supported by regressions excluding lags and are 
not driven by differences in R&D intensity. Without the inclusion of lags, the APD 
coefficients for all groups are slightly lower (which is unsurprising given the time which 
may be required for the effects of cooperation to feed through). However, between-group 
differences have the same direction and are similar in magnitude (about a factor 3 for the 
APD linear coefficient). Therefore, the observed between-group differences in effects do 
not seem to stem from differing ‘feed through time’. Moreover, also without lags, an 
inverted U-shape is only found for development-oriented firms and the differences in 
effects of APD on market novelties again appear strongest. 
3 Result table can be provided upon request. 
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magnitude for research-oriented firms and is significantly larger than for development-
oriented firms (p = 0.0031).  
 
Table 7 Tobit regression estimates: Partner combinations and innovation performance 
Dependent variable: sales 
share of new and sig. 
improved products 
 (1) Partner combinations  
by category  
(2) Partner combinations  
by domestic / abroad 
 Full Research Develop.  Full Research Develop. 
Hor only  5.967 7.410 5.954     
  (4.762) (10.59) (5.206)     
Vert only  3.597* 3.950 3.736*     
  (1.839) (5.030) (1.957)     
Scie only  -4.441 -14.81** -0.899     
  (3.603) (6.651) (4.128)     
Vert & Hor  5.843** 9.521 5.020*     
  (2.629) (6.350) (2.863)     
Scie & Hor  8.885 -3.756 10.70     
  (6.059) (15.07) (6.702)     
Vert & Scie  3.208** 0.099 3.402**     
  (1.496) (3.596) (1.629)     
Vert & Hor & Scie  6.557*** 19.90*** 4.217*     
  (2.053) (4.547) (2.266)     
Domestic only      3.293* -1.113 4.098** 
      (1.770) (4.252) (1.935) 
Abroad only      4.333* -5.353 5.809** 
      (2.555) (6.677) (2.739) 
Domestic & abroad      4.362*** 8.114*** 3.569*** 
      (1.233) (3.068) (1.337) 
         
Controls included         
         
Tot. no. observations   3,757 637 3,120  3,757 637 3,120 
(uncensored)  (3,116) (513) (2,603)  (3,116) (513) (2,603) 
Wald χ2   619.67*** 177.53*** 527.64***  610.38*** 152.59*** 535.09*** 
Prob > χ2  0.000 0.000 0.000  0.000 0.000 0.000 
Log Likelihood  -15,444 -2,533 -12,867  -15,448 -2,543 -12,868 
Notes: Standard errors in parentheses (clustered at the firm level).  
 
For these development-oriented firms, on the other hand, vertical cooperation shows clear 
positive effects. Regardless of whether it is used alone (Vert. only), combined with 
horizontal partners (Vert. & Hor.), combined with science partners (Vert & Scie.) or 
combined with horizontal and science partners (Vert. & Hor. & Scie): vertical 
  
cooperation always appears to exhibit a significant positive effect on the innovation 
performance of development-oriented firms (unlike cooperation which excludes vertical 
partners). Another noteworthy result is the negative coefficient for ‘Science only’ in 
research-oriented firms, with important implications to be discussed below. 
Turning to the results on geographical diversity, no significant differences are 
detected between research- and development-oriented firms for a combination between 
domestic cooperation and cooperation abroad. Still, diversity again appears clearly as the 
most innovation-enhancing strategy for research-oriented firms. 
Discussion 
In sum, the results can be taken as evidence that in their attempts to innovate, 
development-oriented firms (ceteris paribus) benefit from selectivity in favor of vertical 
partners, whereas research-oriented benefit most from diverse alliance portfolios. 
Specifically, the overall effects of APD on innovation performance were found to be 
stronger for research-oriented firms than for development-oriented firms (H1) and only 
for the latter, the typical inverted U-shaped pattern was estimated (H2).1,2 Moreover, the 
research-specific diversity effects were found to be strongest for market novelties (H3) 
and they were found to exist both in terms of partner categories and geography (H4).  
Presumably, these differences in ‘diversity effects’ are attributable to the higher 
marginal benefits which research-oriented firms enjoy when increasing the number of 
partners. These firms tend to face a number of high obstacles in their innovation 
processes (often domestically and abroad), which only a variety of different partners can 
effectively help overcome in combination. Hence, if research-oriented firms use 
collaboration as a ‘coping mechanism’, combining different partners is key for their 
innovative success. Because such diversity helps research-oriented firms overcome 
crucial innovation obstacles, the resulting benefits can be very high and even offset high 
diversity costs. 
For development-oriented firms, however, the costs of diversity should have a 
stronger impact. Here, the (supposedly similar) marginal costs of additional partners are 
larger relative to the (lower) marginal benefits. This gives the marginal costs a higher 
relative weight and makes them catch up with marginal benefits sooner.  
Thus, it is presumably the absence of high marginal benefits (leading to higher net 
costs), which eventually causes the ‘APD-innovation performance relationship’ to tip at 
approximately nine partners for development-oriented firms.3 
                                                
1 Notably, an invered U-shaped pattern for development-oriented firms was estimated for 
all subcomponents of innovative sales (additional result tables are available upon request 
by the authors).  
2 Perhaps, the much higher prevalence of these firms (highly research-intensive firms are 
quite rare) goes some way in explaining the inverted U-shaped patterns, which have 
generally been found in other studies. 
3 Naturally, the reality of rising costs also exists for research-oriented firms: also for these 
firms, the marginal costs are eventually expected to catch up with the marginal benefits 
as the number of partnerships is extended indefinitely. However, the present analysis 
does not capture such an ‘indefinite’ number of partnerships, but only a limited degree of 
diversity. 
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Apart from these different diversity effects, another important finding to discuss are 
the persistent negative effects of ‘Science only’ cooperation for research-oriented firms: 
as shown in the descriptive results, research-oriented firms use this strategy particularly 
frequently (see Table 5). Although partnerships with science organizations seem to be 
valuable for these firms, they appear to be conducive to innovativeness only when they 
are combined with other forms (in the sense of a necessary, but insufficient condition).  
This may be due to various reasons. For instance, from the perspective of a sequential 
adoption of partnerships (Beck & Lopes-Bento, 2015), this partner category may often 
constitute an unsuitable starting point due to its idiosyncratic nature.1 In addition, while 
this partner category seems highly beneficial in the ideation phase and in defining new 
trajectories, it may be less effective in helping a firm transform research findings into 
marketable products and to commercialize them. Together, these factors call for a 
combination of science partnerships with other partnership forms, especially for research-
oriented firms. 
Conclusions 
In their note on the newly established Swiss Innovation Park in Zurich, Sauter Sauter et 
al. (2014, p.61) refer explicitly to ‘research-intensive firms’ in advocating the benefits of 
interacting with diverse partners: 
"To increase innovation, research-intensive firms need to both possess internal 
knowledge and obtain external knowledge from partners, universities, 
competitors, customers and suppliers." 
This indicates that scientists are already (implicitly) aware of the supposed benefits 
which particularly research-oriented firms derive from working with diverse partners. 
This study has presented some first direct evidence for this, by examining the output 
effects of diverse R&D cooperation with a systematic distinction between research- and 
development-oriented firms.  
Indeed, research-oriented firms seem to constitute a (small) subgroup of R&D active 
firms with special attributes. These firms aim at creating novel research-intensive 
products, often with a specific goal to reach new markets, but the hurdles they need to 
overcome on this path are particularly high. Compared to the rest of R&D active firms, 
these firms operate in a much more obscure environment, characterized especially by (a) 
lack of information on the state of technology (b) severe financing and regulatory 
constraints as well as (c) a specific need to transform scientific results into specific 
marketable products. 
In such an environment, drawing from a diverse set of cooperation partners seems 
highly beneficial. The obstacles faced by research-oriented firms are often so diverse that 
no single partner type can be effective in helping to overcome all of them. However, 
different partner types can make a valuable contribution to this end. In other words, if 
R&D collaboration is used by research-oriented firms as a strategy to overcome 
innovation obstacles, combining diverse partners appears as the most promising strategy. 
                                                
1 This idea may be supported by Leiponen and Helfat (2010), who suggest that the 
absorption of scientific knowledge coming from universities is likely to require the 
largest relative amount of absorptive capacity. 
  
Things look differently for development-oriented firms. While these firms are 
expected to face similar marginal costs of additional partners according to the logic of 
transaction cost economics, the benefits they derive from combining different partner 
types are presumably much lower. Together, this leads to higher net costs of diverse 
cooperation strategies for development-oriented firms. Our results are largely in line with 
these ideas. In fact, only for development-oriented firms, an inverted U-shaped effect of 
alliance portfolio diversity on innovation performance is detected over the observed 
range of partners. Consequently, the overall effects of partner diversity on innovation 
performance are also found to be less positive than for research-oriented firms.  
The idea that partner diversity helps research-oriented firms overcome high hurdles 
has further implications for the type of innovation it predominantly supports in these 
firms. Indeed, regressions on subcomponents of innovative sales indicate that the distinct 
effects are strongest on market novelties. 
Further results on the effects of partner combinations largely confirm the ‘research-
specific diversity benefits’ in either of the observed dimensions. Both combining diverse 
partner categories as well as combining domestic with international cooperation appears 
to be highly conducive to the innovation performance of research-oriented firms.  
Most importantly for research-oriented firms (given their frequent use of ‘Science 
only’ cooperation), there is ample evidence that for these firms, relying on a science 
partner is usually not enough. Development-oriented firms, on the other hand, seem to 
benefit from selectivity in terms of their most common partner: these firms’ innovation 
performance is significantly enhanced by cooperation agreements with vertical partners, 
even when these are used in isolation. This is in line with the more continuous innovation 
activity of these firms, supposedly relying heavily on sustained feedback loops along the 
value chain.  
Together, the evidence highlights the importance of alliance portfolio diversity for 
research-oriented firms and of portfolio selectivity for development-oriented firms. In 
light of these results, the firm’s own research or development-orientation may constitute 
an additional important point of reference for managers to assess the firm-specific 
benefits of a diverse collaboration strategy. Whereas strongly development-oriented firms 
need to be especially aware of the downsides of an excessively broad cooperation 
strategy and thus focus on specific partnerships which support their continuous 
development activities, strongly research-oriented firms may want to make more 
extensive use of such diversity. 
The research presented here was still limited in a variety of ways. First, although the 
results of the 5-point Likert scale on expenditures turned out to be highly consistent with 
theory and intuition, it did not allow for an expression of orientation in terms of a truly 
continuous measure. Secondly, the analysis did not systematically consider the various 
complementarities which can exist between ‘R’ and ‘D’ when these are extensively used 
together. Finally, the role of research-orientation needs to be examined much more 
thoroughly. Particularly the exploration of more ‘continuous’ research- and development-
orientation seems to be a worthwhile goal.  
In spite of the limitations of this analysis and all the questions that remain 
unanswered, the importance of separating ‘R’ and ‘D’ in this context seems clear. Such a 
distinction, in combination with the results of previous studies, should lead to important 
new insights aiming to the main goal – an adequate understanding of the firm-specific 
benefits of collaboration diversity. 
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